Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00689130 · ClinicalTrials.gov registry record

ADVANCE: Assessment for Defining Variability in Anesthesia Through Novel Clinical EEG

A clinical trial, sponsored by Medtronic - MITG.

Completed
Registry status
120
Enrollment target

NCT00689130 is a clinical trial that has completed, run by Medtronic - MITG. The registered enrollment target is 120 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00689130 has completed, sponsored by Medtronic - MITG.

COMPLETED
Registry status
120 participants
Enrollment target

Study Summary

The present study is designed to compare prospectively whether sBIS, sEMG, or CVI variability (brain monitoring) can be used to predict unwanted intraoperative responses (high blood pressure, fast heart rate, tearing, etc.) to stimulation (pain) and to determine whether these intraoperative findings are related to patient-assessed postoperative pain scores. The hypothesis is that increases in these variability measures are associated with increased probability of unwanted responses. If confirmed, these variability measures may help anesthesia providers by highlighting periods of inadequate analgesia (pain relief).

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2008-05
Est. Completion 2008-10

Sponsor

Medtronic - MITG

119 total trials

What the Registry Record Tells You About NCT00689130

The ClinicalTrials.gov registry entry for NCT00689130 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00689130 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00689130 about?

NCT00689130 is a clinical study titled "ADVANCE: Assessment for Defining Variability in Anesthesia Through Novel Clinical EEG". The present study is designed to compare prospectively whether sBIS, sEMG, or CVI variability (brain monitoring) can be used to predict unwanted intraoperative responses (high blood pressure, fast heart rate, tearing, etc.) to stimulation (pain) and to determine whether these intraoperative findings...

What is the current status of trial NCT00689130?

This trial is currently completed. The enrollment target is 120 participants. The study started on 2008-05. Estimated completion is 2008-10.

Who is sponsoring clinical trial NCT00689130?

This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.